Brief: Elliptic Laboratories Q3 EBITDA NOK 12.7 Mln
Nov 20 (Reuters) - Elliptic Laboratories ASA ELABS.OL: Q3 TOTAL REVENUE INCREASED BY 49% TO NOK 42.6 MILLION EBITDA IMPROVED TO NOK 12.7 MILLION IN Q3 Source text: ID:nMFNbQ1rjz Further company coverage: ELABS.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))